title: [Study on the risk factors leading to irregularly anti-pulmonary tuberculosis drug taking in patients with smear positive].
abstract: OBJECTIVE
  To describe the current situation and explore risk factors to irregularly antipulmonary tuberculosis(TB) drugs taking in smear positive TB patients.
  
  
  METHODS
  Four out of the forty counties in Chongqing were randomly sampled according to the levels of social and economic development. Totally, 405 new patients with smear positive tuberculosis were systematically sampled and a household survey was carried out. A multiple logistic regression model was fitted to explore the risk factors to irregularly anti-TB drugs taking.
  
  
  RESULTS
  Of valid 401 cases, 50 (12.47%) did not take their drugs regularly and the top 3 reasons for irregular drugs taking were: (1) Adverse effects; (2)Economic hardship; (3) Stopped taking drugs when symptom disappeared. Results from multiple logistic regression analysis showed that factors as: self-perceived economical burden, awareness on TB before being infected and awareness on the fact that if anti-TB drugs can be stopped if the symptoms disappeared, were statistically significant to irregularly drugs taking.
  
  
  CONCLUSIONS
  Strengthening health education program and alleviation of economical burden might serve as two effective measures for regularly drugs taking among TB patients.
authors.affiliation: Chongqing Tuberculosis Center, Chongqing 400050, China.
authors.forename: Dai-yu
authors.initials: DY
authors.lastname: Hu
authors.forename: Tao
authors.initials: T
authors.lastname: Wang
authors.forename: Xiao-yun
authors.initials: XY
authors.lastname: Liu
authors.forename: Jing
authors.initials: J
authors.lastname: Chen
authors.forename: Yang
authors.initials: Y
authors.lastname: Wang
authors.forename: Wei
authors.initials: W
authors.lastname: Zeng
authors.forename: Xiao-fang
authors.initials: XF
authors.lastname: Xu
mesh_terms: D000995:Antitubercular Agents / Q000008:administration & dosage*; D002681:China; D006801:Humans; D010349:Patient Compliance; D012307:Risk Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents